French central bank trims economic outlook

by Aurelia Butler 14 December 2020, 06:00 159 Views

Should zombie companies be feared?

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

French central bank trims economic outlook

Should zombie companies be feared?

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year

ITALIAN LANGUAGE

ENGLISH LANGUAGE